Lv4
534 积分 2020-09-22 加入
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
17小时前
待确认
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
5天前
已完结
Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer: Phase 3 LEAP-006 Study
6天前
已完结
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
7天前
已完结
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
7天前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
8天前
已完结
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
11天前
已完结
Pegfilgrastim safety and efficacy on the last chemotherapy day versus the next: systematic review and meta-analysis
11天前
已完结
Chemoimmunotherapy synergism: mechanisms and clinical applications
18天前
已完结
Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
18天前
已完结
皖公网安备34019202002308
